Marielle E. Yohe, Ph.D.
Affiliations: | 2007 | Pharmacology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Medical Biophysics, PharmacologyGoogle:
"Marielle Yohe"Parents
Sign in to add mentor| John E. Sondek | grad student | 2007 | UNC Chapel Hill | |
| (Regulation of the transforming immortalized mammary protein and its homologs by auto-inhibition and tyrosine phosphorylation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rosenberg EM, Jian X, Soubias O, et al. (2023) The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins. The Journal of Biological Chemistry. 102992 |
| Soubias O, Pant S, Heinrich F, et al. (2020) Membrane surface recognition by the ASAP1 PH domain and consequences for interactions with the small GTPase Arf1. Science Advances. 6 |
| Liu Z, Zhang X, Lei H, et al. (2020) CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG. Nature Communications. 11: 911 |
| Yohe ME, Gryder BE, Chou H, et al. (2020) Abstract B17: MEK inhibition induces myogenic differentiation in RAS-driven rhabdomyosarcoma Molecular Cancer Research. 18 |
| Yeung C, Gibson AE, Issaq SH, et al. (2020) Abstract PR08: Lactate dehydrogenase A is a pharmacologically tractable EWS-FLI1 transcriptional target that regulates the glycolytic dependence of Ewing sarcoma Cancer Research. 80 |
| Liu Z, Zhang X, Lei H, et al. (2020) Abstract B42: Mutant RAS represses CASZ1, a novel regulator of MYOD and MYOG, to inhibit embryonal rhabdomyosarcoma differentiation Cancer Research. 80 |
| Hebron KE, Feehan-Nelson O, Jian X, et al. (2020) Abstract B32: ASAP1 regulates differentiation in myoblasts and PAX-FOXO1 fusion-negative rhabdomyosarcoma Cancer Research. 80 |
| Cheuk A, Shivaprasad N, Schneider D, et al. (2020) Abstract A08: Development of FGFR4-specific chimeric antibody receptor (CAR) T cell and bispecific T cell engager (BiTE) for rhabdomyosarcoma (RMS) immunotherapy Cancer Research. 80 |
| Roy NS, Jian X, Soubias O, et al. (2019) Interaction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphate. The Journal of Biological Chemistry |
| Yeung C, Gibson AE, Issaq SH, et al. (2019) Targeting glycolysis through inhibition of lactate dehydrogenase impairs tumor growth in preclinical models of Ewing sarcoma. Cancer Research |